Exchange: NASDAQ·Updated 05:51 PM EDT
IDXX logo

IDXXIdexx Laboratories Inc

$557.80
$20.22
(3.76%)
Today
Closed $557.80
$0.00
(0.00%)
After Hours
EarningsAug 4
Mkt Cap$44B
Vol813,893.00
News
all
press releases
IDEXX Laboratories to Release 2026 Second Quarter Financial Results
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2026 second quarter financial results for Tuesday, August 4, 2026, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that...
Business Wire
News Placeholder
More News
News Placeholder
Why Idexx Laboratories (IDXX) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks
News Placeholder
Is the Options Market Predicting a Spike in IDEXX Laboratories Stock?
Investors need to pay close attention to IDXX stock based on the movements in the options market lately.
Zacks
News Placeholder
Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 10 Years
read more...
Benzinga
News Placeholder
Here's Why Idexx Laboratories (IDXX) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
News Placeholder
Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
News Placeholder
Idexx (IDXX) Down 3.2% Since Last Earnings Report: Can It Rebound?
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
News Placeholder
IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the expansion of its Fecal Dx antigen testing platform with taeniid tapeworm, including Taenia and Echinococcus species. Proven to detect up to twice as many intestinal parasite infections earlier...
Business Wire
News Placeholder
IDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry Profiles
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that SDMA, a renal biomarker, will be built into Catalyst CLIPs, making complete kidney function evaluation part of the most common point-of-care chemistry profiles. Available beginning in June to...
Business Wire
News Placeholder
The Biology Came First.
MindWalk Holdings Corp. (NASDAQ: HYFT) today released a systematic report identifying over 20 discovery-originated drug candidates with documented origins in antibody discovery work performed at...
Business Wire
<
1
2
...
>

Advertisement|Remove ads.